Empagliflozin belongs to a class of drugs called SGLT2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream through urine, thus lowering blood sugar levels. Metformin belongs to the biguanide class of medications and works primarily by decreasing the amount of glucose produced by the liver and improving the body’s response to insulin.